Clinical Laboratory Services Market Analysis By Test (Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests), By Service Provider (Hospitals, Stand-Alone Laboratories, Clinics) And Segment Forecasts To 2020
Global clinical laboratory services market is expected to reach USD 261.42 billion by 2020. The demand for early diagnosis in order to render effective therapeutic interventions is on a constant rise. Wide range of diagnostic tests encompassed in the clinical laboratory services segment coupled with increasing incidence rates of infectious and chronic diseases is expected to drive market growth during the forecast period. In addition, presence of untapped growth opportunities and the rapidly improving healthcare infrastructure in emerging markets such as China, India and Brazil are expected to offer growth opportunities for industry participants.
Clinical chemistry based services dominated the overall market, accounting for over 45.0% of the revenue share in 2013, owing to the fact that these tests are a part of the initial disease diagnostic process and thus are carried out in large volumes.
Further key findings from the study suggest:
Human & tumor genetics followed clinical chemistry tests in terms of revenue. The market for human & tumor genetics is expected to grow at a CAGR of over 6.0% from 2014 to 2020 majorly owing to increasing global incidence rates of cancer.
Stand alone laboratories are expected to witness significant gains over the forecast period. Growing use of these laboratories in emerging and underdeveloped economies in an attempt to improve healthcare access is expected to be the primary growth driver for this segment.
North America dominated the overall clinical laboratory services market in terms of revenue share in 2013, majorly on account of the presence of high prevalence levels of chronic and infectious diseases and sophisticated reimbursement networks.
Asia Pacific is expected to be a high-growth clinical laboratory services market over the forecast period. Growing demand for proper diagnostics and rapidly improving healthcare infrastructure in the emerging markets of China and India are some factors attributing to its rapid growth rate.
Some key market players of clinical laboratory services include Genoptix Medical Laboratory, Quest Diagnostics Inc., LabCorp, Sonic Healthcare, Labco S.A., Charles River Laboratories, Bio-Reference Laboratories, Abbott Laboratories and Healthscope.
The market has witnessed a surge in R&D spending in recent times, aimed at developing technologically advanced products and systems to provide precise result even when dealing with large sample volumes.
For the purpose of this study, Grand View Research has segmented the global clinical laboratory services market on the basis of test type, service provider and region:
Clinical chemistry based services dominated the overall market, accounting for over 45.0% of the revenue share in 2013, owing to the fact that these tests are a part of the initial disease diagnostic process and thus are carried out in large volumes.
Further key findings from the study suggest:
Human & tumor genetics followed clinical chemistry tests in terms of revenue. The market for human & tumor genetics is expected to grow at a CAGR of over 6.0% from 2014 to 2020 majorly owing to increasing global incidence rates of cancer.
Stand alone laboratories are expected to witness significant gains over the forecast period. Growing use of these laboratories in emerging and underdeveloped economies in an attempt to improve healthcare access is expected to be the primary growth driver for this segment.
North America dominated the overall clinical laboratory services market in terms of revenue share in 2013, majorly on account of the presence of high prevalence levels of chronic and infectious diseases and sophisticated reimbursement networks.
Asia Pacific is expected to be a high-growth clinical laboratory services market over the forecast period. Growing demand for proper diagnostics and rapidly improving healthcare infrastructure in the emerging markets of China and India are some factors attributing to its rapid growth rate.
Some key market players of clinical laboratory services include Genoptix Medical Laboratory, Quest Diagnostics Inc., LabCorp, Sonic Healthcare, Labco S.A., Charles River Laboratories, Bio-Reference Laboratories, Abbott Laboratories and Healthscope.
The market has witnessed a surge in R&D spending in recent times, aimed at developing technologically advanced products and systems to provide precise result even when dealing with large sample volumes.
For the purpose of this study, Grand View Research has segmented the global clinical laboratory services market on the basis of test type, service provider and region:
- Global Clinical Laboratory Services Test Outlook (Revenue, USD Billion, 2012 – 2020)
- Human & Tumor Genetics
- Clinical Chemistry
- Medical Microbiology & Cytology
- Other Esoteric Tests
- Global Clinical Laboratory Services, Service Provider Outlook (Revenue, USD Billion, 2012 – 2020)
- Hospital-Based Laboratories
- Stand-Alone Laboratories
- Clinic-Based Laboratories
- Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2012 – 2020)
- North America
- Europe
- Asia Pacific
- RoW
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Clinical Laboratory Services– Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. CLINICAL LABORATORY SERVICES INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Clinical Laboratory Services Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Clinical Laboratory Services- Company Market Share Analysis
2.7. Clinical Laboratory Services Market PESTEL Analysis, 2012
CHAPTER 3. CLINICAL LABORATORY SERVICES TEST OUTLOOK
3.1. Human & Tumor Genetics
3.1.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.2. Clinical Chemistry
3.2.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.3. Medical Microbiology & Cytology
3.3.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.4. Other Esoteric Tests
3.4.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
CHAPTER 4. CLINICAL LABORATORY SERVICES SERVICE PROVIDER OUTLOOK
4.1. Hospital-Based Laboratories
4.1.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
4.2. Stand-Alone Laboratories
4.2.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
4.3. Clinic-Based Laboratories
4.3.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
CHAPTER 5. CLINICAL LABORATORY SERVICES REGIONAL OUTLOOK
5.1. North America
5.1.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.1.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.2. Europe
5.2.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.2.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.3. Asia Pacific
5.3.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.3.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.4. RoW
5.4.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.4.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
CHAPTER 6 CLINICAL LABORATORY SERVICES COMPETITIVE LANDSCAPE
6.1 Siemens
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Charles River Laboratories
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Quest Diagnostics, Inc.
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Bioscientia Healthcare
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Sonic Healthcare Limited
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Abbott Laboratories
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Bio-Reference Laboratories
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Labco S.A.
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 Healthscope Ltd.
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Spectra Laboratories
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 Laboratory Corporation Of America Holdings (Labcorp)
6.11.1 Company Overview
6.11.2 Financial Performance
6.11.3 Product Benchmarking
6.11.4 Strategic Initiatives
6.12 ARUP Laboratories
6.12.1 Company Overview
6.12.2 Financial Performance
6.12.3 Product Benchmarking
6.12.4 Strategic Initiatives
6.13 Genoptix Medical Laboratory
6.13.1 Company Overview
6.13.2 Financial Performance
6.13.3 Product Benchmarking
6.13.4 Strategic Initiatives
6.14 Qiagen
6.14.1 Company Overview
6.14.2 Financial Performance
6.14.3 Product Benchmarking
6.14.4 Strategic Initiatives
6.15 Clarient Inc.
6.15.1 Company Overview
6.15.2 Financial Performance
6.15.3 Product Benchmarking
6.15.4 Strategic Initiatives
6.16 Genzyme Corporation
6.16.1 Company Overview
6.16.2 Financial Performance
6.16.3 Product Benchmarking
6.16.4 Strategic Initiatives
CHAPTER 7. METHODOLOGY AND SCOPE
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
1.1. Clinical Laboratory Services– Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. CLINICAL LABORATORY SERVICES INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Clinical Laboratory Services Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Clinical Laboratory Services- Company Market Share Analysis
2.7. Clinical Laboratory Services Market PESTEL Analysis, 2012
CHAPTER 3. CLINICAL LABORATORY SERVICES TEST OUTLOOK
3.1. Human & Tumor Genetics
3.1.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.2. Clinical Chemistry
3.2.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.3. Medical Microbiology & Cytology
3.3.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
3.4. Other Esoteric Tests
3.4.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
CHAPTER 4. CLINICAL LABORATORY SERVICES SERVICE PROVIDER OUTLOOK
4.1. Hospital-Based Laboratories
4.1.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
4.2. Stand-Alone Laboratories
4.2.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
4.3. Clinic-Based Laboratories
4.3.1. Market Estimates and Forecasts, 2012 – 2020 (USD Billion)
CHAPTER 5. CLINICAL LABORATORY SERVICES REGIONAL OUTLOOK
5.1. North America
5.1.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.1.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.2. Europe
5.2.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.2.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.3. Asia Pacific
5.3.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.3.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
5.4. RoW
5.4.1. Market Estimates and Forecasts, by Test Type, 2012 – 2020 (USD Billion)
5.4.2. Market Estimates and Forecasts, by Service Provider, 2012 – 2020 (USD Billion)
CHAPTER 6 CLINICAL LABORATORY SERVICES COMPETITIVE LANDSCAPE
6.1 Siemens
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Charles River Laboratories
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Quest Diagnostics, Inc.
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Bioscientia Healthcare
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Sonic Healthcare Limited
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Abbott Laboratories
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Bio-Reference Laboratories
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Labco S.A.
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 Healthscope Ltd.
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Spectra Laboratories
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 Laboratory Corporation Of America Holdings (Labcorp)
6.11.1 Company Overview
6.11.2 Financial Performance
6.11.3 Product Benchmarking
6.11.4 Strategic Initiatives
6.12 ARUP Laboratories
6.12.1 Company Overview
6.12.2 Financial Performance
6.12.3 Product Benchmarking
6.12.4 Strategic Initiatives
6.13 Genoptix Medical Laboratory
6.13.1 Company Overview
6.13.2 Financial Performance
6.13.3 Product Benchmarking
6.13.4 Strategic Initiatives
6.14 Qiagen
6.14.1 Company Overview
6.14.2 Financial Performance
6.14.3 Product Benchmarking
6.14.4 Strategic Initiatives
6.15 Clarient Inc.
6.15.1 Company Overview
6.15.2 Financial Performance
6.15.3 Product Benchmarking
6.15.4 Strategic Initiatives
6.16 Genzyme Corporation
6.16.1 Company Overview
6.16.2 Financial Performance
6.16.3 Product Benchmarking
6.16.4 Strategic Initiatives
CHAPTER 7. METHODOLOGY AND SCOPE
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
LIST OF TABLES
1. Clinical Laboratory Services– Industry summary &Critical Success Factors (CSFs)
2. Global clinical laboratory services revenue, 2012 - 2020
3. Global clinical laboratory services market revenue by region, (USD billion), 2012 - 2020
4. Global clinical laboratory services market revenue by Test Type, (USD billion), 2012 – 2020
5. Global human & tumor genetics market, 2012 to 2020 (USD billion)
6. Global clinical chemistry market, 2012 to 2020 (USD billion)
7. Global medical microbiology & cytology market, 2012 to 2020 (USD billion)
8. Global other esoteric tests market, 2012 to 2020 (USD billion)
9. Global clinical laboratory services market revenue by Service Provider, (USD billion), 2012 – 2020
10. Hospital-based laboratories market, 2012 to 2020 (USD billion)
11. Stand-alone laboratories market, 2012 to 2020 (USD billion)
12. Clinic-based laboratories market, 2012 to 2020 (USD billion)
13. Global Clinical Laboratory Services market, by region, 2012 to 2020 (USD billion)
14. North America Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
15. North America Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
16. Europe Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
17. Europe Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
18. Asia Pacific Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
19. Asia Pacific Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
20. RoW Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
21. RoW Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
22. Global Clinical Laboratory Services Market - Competitive Landscape
1. Clinical Laboratory Services– Industry summary &Critical Success Factors (CSFs)
2. Global clinical laboratory services revenue, 2012 - 2020
3. Global clinical laboratory services market revenue by region, (USD billion), 2012 - 2020
4. Global clinical laboratory services market revenue by Test Type, (USD billion), 2012 – 2020
5. Global human & tumor genetics market, 2012 to 2020 (USD billion)
6. Global clinical chemistry market, 2012 to 2020 (USD billion)
7. Global medical microbiology & cytology market, 2012 to 2020 (USD billion)
8. Global other esoteric tests market, 2012 to 2020 (USD billion)
9. Global clinical laboratory services market revenue by Service Provider, (USD billion), 2012 – 2020
10. Hospital-based laboratories market, 2012 to 2020 (USD billion)
11. Stand-alone laboratories market, 2012 to 2020 (USD billion)
12. Clinic-based laboratories market, 2012 to 2020 (USD billion)
13. Global Clinical Laboratory Services market, by region, 2012 to 2020 (USD billion)
14. North America Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
15. North America Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
16. Europe Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
17. Europe Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
18. Asia Pacific Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
19. Asia Pacific Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
20. RoW Clinical Laboratory Services demand, by Test Type, (USD billion), 2012 – 2020
21. RoW Clinical Laboratory Services demand, by Service Provider, (USD billion), 2012 - 2020
22. Global Clinical Laboratory Services Market - Competitive Landscape
LIST OF FIGURES
1. Clinical Laboratory Services Market Segmentation
2. Global Clinical Laboratory Services Market Revenue, 2012 - 2020
3. Clinical Laboratory Services Market Dynamics
4. Clinical Laboratory Services Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. Clinical Laboratory Services PESTEL Analysis, 2012
8. Global Clinical Laboratory Services market, by Test Type, (USD billion), 2012 – 2020
9. Global human & tumor genetics market, by region, (USD billion), 2012 – 2020
10. Global clinical chemistry market, by region, (USD billion), 2012 – 2020
11. Global medical microbiology & cytology market, by region, (USD billion), 2012 – 2020
12. Global other esoteric tests market, by region, (USD billion), 2012 – 2020
13. Global Clinical Laboratory Services market, by Service Provider, (USD billion), 2012 – 2020
14. Global hospital-based laboratories market, by region, (USD billion), 2012 – 2020
15. Global stand-alone laboratories market, by region, (USD billion), 2012 – 2020
16. Global clinic-based laboratories market, by region, (USD billion), 2012 – 2020
17. Clinical Laboratory Services market - company market share analysis, 2013 (%)
1. Clinical Laboratory Services Market Segmentation
2. Global Clinical Laboratory Services Market Revenue, 2012 - 2020
3. Clinical Laboratory Services Market Dynamics
4. Clinical Laboratory Services Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. Clinical Laboratory Services PESTEL Analysis, 2012
8. Global Clinical Laboratory Services market, by Test Type, (USD billion), 2012 – 2020
9. Global human & tumor genetics market, by region, (USD billion), 2012 – 2020
10. Global clinical chemistry market, by region, (USD billion), 2012 – 2020
11. Global medical microbiology & cytology market, by region, (USD billion), 2012 – 2020
12. Global other esoteric tests market, by region, (USD billion), 2012 – 2020
13. Global Clinical Laboratory Services market, by Service Provider, (USD billion), 2012 – 2020
14. Global hospital-based laboratories market, by region, (USD billion), 2012 – 2020
15. Global stand-alone laboratories market, by region, (USD billion), 2012 – 2020
16. Global clinic-based laboratories market, by region, (USD billion), 2012 – 2020
17. Clinical Laboratory Services market - company market share analysis, 2013 (%)
